Literature DB >> 21085042

Cardiovascular risk and clinical factors in athletes: 10 years of evaluation.

Luciana Diniz Nagem Janot De Matos1, Natalia De Almeida Ordacgi Caldeira, Patricia De Sa Perlingeiro, Igor Lucas Gomes dos Santos, Carlos Eduardo Negrao, Luciene Ferreira Azevedo.   

Abstract

PURPOSE: Preparticipation screening in athletes is a very current but controversial theme. Part of this controversy is due to the cost benefit, especially when the screening is merely used as a prevention of sudden cardiac death caused by rare and hereditary diseases. The purpose of this study was to describe the prevalence of preexisting diseases, cardiovascular risk factor for cardiovascular diseases development, and hematological profile in a population of amateur and professional athletes.
METHODS: Data of 623 athletes (529 men and 94 women), aged 13-77 yr, were analyzed to detect preexisting diseases. The variables total cholesterol, LDL, HDL, triglycerides, fasting glucose, body mass index, hemoglobin, hematocrit, and ferritin were analyzed in two groups according to age, that is, younger and older 35 yr old, and their prevalence (%) and distribution in quartiles were presented. χ test and Pearson product-moment correlation coefficients between variables were applied, and P < 0.05 was adopted for significance.
RESULTS: Hypertension was the most prevalent preexisting diseases, although the data showed low prevalence of cardiomyopathy. Cardiovascular risk factors were prevalent in both genders. There were positive correlations between cardiovascular risk factors and age and between body mass index and lipid levels in male athletes. Also, there was a high prevalence of low ferritin levels for women, with positive correlation between the levels of hemoglobin and ferritin.
CONCLUSIONS: In the present study, hypertension was the most prevalent diagnosed disease, and cardiovascular risk factors showed important prevalence, especially in athletes older than 35 yr. Although physical training represents a cardioprotective factor to the onset of cardiovascular disease, it does not exclude the prevalence of risk factors and diseases in athletes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21085042     DOI: 10.1249/MSS.0b013e318203d5cb

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  9 in total

1.  Ultra-endurance sports have no negative impact on indices of arterial stiffness.

Authors:  Thomas Radtke; Arno Schmidt-Trucksäss; Nicolas Brugger; Daniela Schäfer; Hugo Saner; Matthias Wilhelm
Journal:  Eur J Appl Physiol       Date:  2013-10-19       Impact factor: 3.078

Review 2.  Hypertension in Athletes and Active Populations.

Authors:  Kevin T Schleich; M Kyle Smoot; Michael E Ernst
Journal:  Curr Hypertens Rep       Date:  2016-11       Impact factor: 5.369

3.  Olympic Cycle Comparison of the Nutritional and Cardiovascular Health Status of an Elite-Level Female Swimmer: Case Study Report from Slovenia.

Authors:  Boštjan Jakše; Silvester Lipošek; Nataša Zenić; Dorica Šajber
Journal:  Sports (Basel)       Date:  2022-04-20

4.  Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.

Authors:  Sascha Ketelhut; Ingomar W Franz; Reinhard G Ketelhut
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-10-20

5.  Brachial and central blood pressure and arterial stiffness in adult elite athletes.

Authors:  Fabian Tomschi; Hannah Ottmann; Wilhelm Bloch; Marijke Grau; Hans-Georg Predel
Journal:  Eur J Appl Physiol       Date:  2021-03-13       Impact factor: 3.078

6.  Assessment of cardiovascular risk and preparticipation screening protocols in masters athletes: the Masters Athlete Screening Study (MASS): a cross-sectional study.

Authors:  Barbara N Morrison; James McKinney; Saul Isserow; Daniel Lithwick; Jack Taunton; Hamed Nazzari; Astrid M De Souza; Brett Heilbron; Carlee Cater; Mackenzie MacDonald; Benjamin A Hives; Darren E R Warburton
Journal:  BMJ Open Sport Exerc Med       Date:  2018-08-09

7.  Cardiovascular Risk and Disease Among Masters Endurance Athletes: Insights from the Boston MASTER (Masters Athletes Survey To Evaluate Risk) Initiative.

Authors:  Kayle Shapero; James Deluca; Miranda Contursi; Meagan Wasfy; Rory B Weiner; Gregory D Lewis; Adolph Hutter; Aaron L Baggish
Journal:  Sports Med Open       Date:  2016-08-09

Review 8.  Health and Well-Being of Athletes During the Coronavirus Pandemic: A Scoping Review.

Authors:  Raven Haan; Mariyam Essa Ali Alblooshi; Dawood Hasan Syed; Khaled Khalifa Dougman; Hashel Al Tunaiji; Luciana Aparecida Campos; Ovidiu Constantin Baltatu
Journal:  Front Public Health       Date:  2021-04-16

Review 9.  The Female Athlete's Heart: Overview and Management of Cardiovascular Diseases.

Authors:  Silvia Castelletti; Sabiha Gati
Journal:  Eur Cardiol       Date:  2021-12-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.